Table 1 Summary of the laboratory findings obtained on cerebrospinal fluid, blood, and urine samples before (dol 11) and after 25 days of Valganciclovir therapy (dol 45)
Findings | Dol 11 | Dol 45 |
|---|---|---|
Cerebrospinal Fluid | ||
Proteins | 67,9 mg/dL | 59,0 mg/dL |
White Cells | 12 cells/μL | 9 cells/μL |
Red Cells | 141 cells/μL | 373 cells/μL |
CMV-DNA | 2.835.371 GC/ml | Negative |
GCV | - | 0,52 μg/ml |
Blood | ||
CMV-DNA | 115.068 GC/ml | 821 GC/ml |
GCV (trough) | - | 0,53 μg/ml |
GCV (peak) | - | 5,54 μg/ml |
Urine | ||
CMV-DNA | >25.000.000 GC/ml | 619.137 GC/ml |